Skip to main content

Day: March 15, 2021

Patagonia Exercises Option to Acquire Latin Metals’ Mina Angela Project, Chubut Province, Argentina

VANCOUVER, British Columbia, March 15, 2021 (GLOBE NEWSWIRE) —  Latin Metals Inc. (“Latin Metals” or the “Company”) – (TSXV: LMS) (OTCQB: LMSQF) announces that it has received an option exercise notice from Patagonia Gold Corp. (“Patagonia”), pursuant to an option agreement (the “Option Agreement”) among Patagonia, Latin Metals and an Argentine subsidiary of Latin Metals, whereby Patagonia was granted an irrevocable option (the “Option”) to acquire a 100% interest in the Mina Angela project (the “Project” or “Mina Angela”), located in the Province of Chubut, Argentina.In connection with exercise of the Option, Patagonia (through its subsidiary) will make a cash payment to Latin Metals of US$250,000 pursuant to the terms of the Option Agreement, which payment is due on or before March 26, 2021 (Table 1). Pursuant to the terms...

Continue reading

Salona Global Medical Device Corporation Announces Approval of Change of Business, First Acquisition

SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) — Salona Global Medical Device Corporation (formerly Brattle Street Investment Corp.) (the “Company” or “Salona Global”) (TSXV:SGMD) today announced the approval of all items of business disclosed in the management information circular dated January 26, 2021 (the “Circular”) at the previously announced annual general and special shareholders’ meeting (the “Meeting”). Included in the business of the Meeting was the resolution to adopt the Change of Business as defined by the TSX Venture Exchange and to approve the first acquisition for the Company (the “Transaction”). All items of business were approved with overwhelming majorities.“We’re pleased with the outcome of the Meeting” said Les Cross, Chairman of Salona Global, “With the successful resolution of our shareholder vote we are taking...

Continue reading

Marksmen Announces Its 2021 Drilling Program with the Continuation of Its Strategic 40 Well Recomplete Program and Other Development Opportunities in Ohio, USA

CALGARY, Alberta, March 15, 2021 (GLOBE NEWSWIRE) — Marksmen Energy Inc. (“Marksmen” or the “Company”) (TSXV: MAH) (OTCQB: MKSEF) is pleased to announce the following:Portage County, Ohio – Marksmen has a Joint Operating Agreement with PEP Drilling LLC (“PEP”) of Ohio, to recomplete up to 40 Clinton Sandstone formation wells in Portage County, Ohio. Under the terms of the agreement Marksmen would pay 100% of the capital costs to earn an 80% working interest until 125% of capital payback is reached.The Clinton Sandstone is historically one of the most prolific producing formations in Ohio, spread over several counties, with many thousands of wells drilled. The recompletes in this 40 well program are in wells that originally targeted a deeper zone and bypassed the Clinton Sandstone formation entirely and left it untapped. Management...

Continue reading

GeoVax to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update

Conference call to be held Wednesday, March 24, at 8:00 a.m. Eastern TimeATLANTA, GA, March 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire  — GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, announces today that it plans to report 2020 financial results on Tuesday, March 23, 2021 after the market closes.Management will host a conference call at 8:00 a.m. ET on Wednesday, March 24, 2021 to review financial results and provide an update on corporate developments.  Following management’s formal remarks, there will be a question and answer session.Participants are asked to pre-register for the call via the following link: https://dpregister.com/sreg/10152894/e3a3a9bd2cPlease note that registered participants will receive their dial-in...

Continue reading

Progress Software to Report First Quarter Financial Results on March 25, 2021

BEDFORD, Mass., March 15, 2021 (GLOBE NEWSWIRE) — Progress (NASDAQ: PRGS), the leading provider of products to develop, deploy and manage high-impact business applications, today announced that it will release financial results for its fiscal first quarter, after the market close on Thursday, March 25, 2021. The company’s fiscal first quarter ended on February 28, 2021.Progress will host a conference call to review and discuss the results at 5:00 p.m. ET the same day.Conference Call DetailsThe conference call may be accessed via investors.progress.com or dial-in at 800-367-2403 or 334-777-6978, passcode 3276569. Please join the conference call at least 10 minutes early to register.An archived version of the conference call and supporting materials will be available on the Progress Investor Relations webpage after the live conference...

Continue reading

Adamis Pharmaceuticals Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model

SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) (“Company”) announced today that in studies conducted at Galveston National Laboratory (GNL), University of Texas Medical Branch (UTMB) at Galveston, hamsters challenged with the virus that causes COVID-19 (SARS-CoV-2), resulted in decreased inflammation in the lungs of animals treated with Tempol compared to controls. This is the first data demonstrating that Tempol, a novel antioxidant, can reduce inflammation in animals given the virus (SARS-CoV-2) that causes COVID-19. The group plans on submitting the publication to a peer review journal.Dr. Chien-Te Kent Tseng, Professor of the Department of Microbiology and Immunology and Director of GNL’s SARS/MERS/COVID-19 Laboratory at UTMB, commented on these results: “In our hamster...

Continue reading

BioStem Technologies Engages D. Brooks & Associates for 2020 and 2019 Audit

Pompano Beach, Fl., March 15, 2021 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a leading pre-clinical-stage biotechnology company focused on harnessing elements of Perinatal Tissue for use in regenerative therapies, today announced it engaged D. Brooks and Associates CPA’s, P.A. as the Company’s PCAOB registered certified public accounting firm for the 2020 and 2019 fiscal years.We expect the audit to be complete sometime in the second quarter of 2021. Upon completion of the audit, BioStem intends to examine the possibility of becoming fully reporting with the SEC.BioStem ‘s CEO, Jason Matuszewski, said, “We believe this is the appropriate time to hire a PCAOB auditor, as it aligns with our capital markets and reporting company goals.”About...

Continue reading

PLUMAS BANCORP RELOCATES ITS CORPORATE HEADQUATERS TO RENO, NEVADA

RENO, Nev., March 15, 2021 (GLOBE NEWSWIRE) — Plumas Bancorp (Nasdaq:PLBC), the parent company of Plumas Bank, today announced the relocation of its corporate office to 5525 Kietzke Ln., Reno, Nevada. The move by Plumas Bancorp demonstrates its ongoing commitment to increase services for businesses based in the Northern Nevada region. Plumas Bank first opened a loan production office in Reno in 2006 followed by branches in Reno and Carson City in 2015 and 2018, respectively.“Northern Nevada continues to attract a diverse base of small businesses, and those business owners need access to capital to thrive and expand,” said Andrew J. Ryback, president and CEO of Plumas Bancorp and Plumas Bank. “As a community bank, we serve the small to mid-sized businesses that are often overlooked by larger financial institutions or that need more...

Continue reading

Hudson Initiates Metallurgical Testwork Program on the Nukittooq Niobium – Tantalum Project in Greenland

VANCOUVER, British Columbia, March 15, 2021 (GLOBE NEWSWIRE) — HUDSON RESOURCES INC. (“Hudson” or the “Company”) (TSX Venture Exchange “HUD”; OTC “HUDRF”) is pleased to announce that metallurgical testwork has commenced on samples from the Nukittooq niobium – tantalum project (“Nukittooq project”) in Greenland. The testwork is being undertaken at SGS Lakefield, Canada, on high-grade niobium tantalum grab samples collected in 2020, under the supervision of Hudson’s consulting Metallurgist, John Goode.The Nukittooq project occurs within the 100% owned exploration license that covers the Sarfartoq Carbonatite Complex in southeast Greenland. This exploration license also hosts the Company’s ST1 rare earth element (REE) project where Hudson has completed a NI 43-101 Technical Report which outlined a resource of 24 million kg of...

Continue reading

Flexion Therapeutics to Present at the Oppenheimer 31st Annual Virtual Healthcare Conference

BURLINGTON, Mass., March 15, 2021 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Oppenheimer 31st Annual Healthcare Conference. The virtual fireside chat is scheduled to begin at 10:00 a.m. ET on Wednesday, March 17, 2021.To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.About Flexion TherapeuticsFlexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company’s core values are focus, ingenuity,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.